Intriguingly, studies have demonstrated that activation of murine tumor lysate-pulsed dendritic cells by CD40L leads to a more vigorous induction of systemic immunity as compared to cells prepared without CD40L activation [16]. Here, CD40LG is linked to neoplasm.